시장보고서
상품코드
1855954

세계의 POC(Point Of Care) 지질 검사 시장 보고서(2025년)

Point Of Care Lipid Test Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

POC(Point Of Care) 지질 검사 시장 규모는 최근 강력하게 성장하고 있습니다. 2024년 6억 8,000만 달러에서 2025년에는 7억 4,000만 달러로, CAGR 9.9%로 확대합니다. 지난 기간 중 성장의 원동력은 심혈관 질환 및 이상지질혈증 유병률 증가, 다항목 및 다검사 확대, 의료비 지출 증가 및 상환 지원, 예방 의료에 대한 인식 증가 및 강조, 소매 약국, 진료소 및 지역 사회에서의 폭넓은 채택입니다.

POC(Point-Of-Care) 지질 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.5%로 10억 7,000만 달러로 성장할 것입니다. 예측 기간 중 성장의 원동력은 재택 및 자가 모니터링 환경에서의 채택 증가, 유전성 이상지질혈증에 대한 인식 및 검진 증가, 만성질환 부담 증가, 가치 기반 의료 모델로의 전환, 소모품에 대한 안정적 수요 등이 될 것입니다. 예측 기간 중 주요 동향으로는 휴대용 기술의 발전, 디지털 헬스 시스템과의 통합, 원격 환자 모니터링 및 원격의료 플랫폼에 대한 통합, IoT 및 커넥티드 헬스 인프라에 대한 통합, 엣지 컴퓨팅 및 저전력 바이오센서 칩의 개발 등이 있습니다. 등을 들 수 있습니다.

Point Of Care 지질검사는 중앙연구소에 검체를 보내지 않고 손가락으로 채혈하여 콜레스테롤과 중성지방 수치를 측정하는 신속 진단 검사입니다. 심혈관계 위험 평가 및 지속적인 모니터링을 지원하기 위해 신속한 결과를 제공합니다.

주요 제품 유형은 장비, 소모품, 기타 등입니다. 이 장비에는 환자의 진료 현장 또는 그 근처에서 콜레스테롤 수치, 중성지방 수치와 같은 지질 프로파일을 신속하게 평가할 수 있도록 설계된 휴대용 분석기 및 검사 장비가 포함됩니다. 이 솔루션은 고지혈증, 고중성지방혈증, 고트리글리세리드혈증, 탕헤르병, 고지단백혈증, 가족성 고콜레스테롤혈증 등의 병증에 적용됩니다. 주요 최종사용자로는 병원, 진료소, 진단 실험실, 재택치료 현장 등이 있습니다.

미국의 급격한 관세 인상과 그에 따른 2025년 봄의 무역 마찰은 의료기기 분야, 특히 수입 영상 진단기기 부품, 수술용 스테인리스강, 플라스틱 소모품에 큰 영향을 미치고 있습니다. 병원 및 진료소는 가격 인상에 저항하며 제조업체의 이윤을 압박하고 있습니다. 관세와 관련된 공급업체 변경은 종종 장비의 재인증을 요구하고 시장 출시 시간을 지연시키는 등 규제상의 장애물이 문제를 복잡하게 만들고 있습니다. 기업은 핵심 부품의 이중 조달, 상품화된 품목의 국내 생산 확대, 비용 효율적인 소재의 연구개발 가속화 등을 통해 리스크를 줄이고 있습니다.

이 조사 보고서는 POC(Point-Of-Care) 지질 검사 산업 세계 시장 규모, 지역 점유율, POC(Point-Of-Care) 지질 검사 시장 점유율을 가진 경쟁사, 상세한 POC(Point-Of-Care) 지질 검사 시장 부문, 시장 동향, 비즈니스 기회 등 POC(Point-Of-Care) 지질 검사 시장 통계를 제공하고, POC(Point-Of-Care) 지질 검사 산업에서 성공하기 위해 필요한 데이터를 제공합니다. The Business Research Company의 새로운 보고서 시리즈 중 하나로, POC(Point-Of-Care) 지질 검사 산업에서 성공하기 위해 필요한 데이터를 제공합니다. 이 POC(Point-Of-Care) 지질 검사 시장 조사 보고서는 업계의 현재와 미래 시나리오를 자세히 분석하여 필요한 모든 것을 완벽한 관점으로 제공합니다.

심혈관 질환의 유병률 증가는 POC(Point-Of-Care) 지질 검사 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환에는 관상동맥질환, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 질환이 포함되며, 대부분 콜레스테롤과 중성지방 수치 이상과 관련된 동맥경화에 기인하는 경우가 많습니다. 심혈관 질환 증가는 비만, 혈액순환 장애, 기타 위험요인을 유발하는 좌식 생활습관과 운동량 감소에 기인하는 바가 큽니다. 현장 진료 지질 검사는 콜레스테롤과 지질 수치를 그 자리에서 신속하게 측정하여 위험을 조기에 발견하고 적시에 개입하여 추가 합병증을 예방할 수 있도록 함으로써 이러한 추세를 관리하는 데 중요한 역할을 하고 있습니다. 예를 들어 미국심장협회가 2024년 1월에 보고한 바에 따르면 심혈관 질환으로 인한 사망자 수는 93만 1,578명으로 전년 대비 3,000명 증가했습니다. 이처럼 심혈관계 질환의 부담이 증가함에 따라 현장 진료용 지질 검사에 대한 수요가 증가하고 있습니다.

point-of-care 지질 검사 시장의 주요 기업은 임상적 의사결정과 환자 관리를 개선하기 위해 고급 진단 플랫폼에 초점을 맞추었습니다. 이 플랫폼은 환자의 침대 옆에서 신속하고 실험실 수준의 지질 패널 검사를 수행할 수 있는 휴대용 통합 장치로, 실시간 의사결정과 즉각적인 치료를 가능하게 합니다. 예를 들어 2023년 7월 캐나다에 본사를 둔 헬스케어 기업 바이탈 바이오사이언스(Vital Biosciences)는 바이탈원 플랫폼(Vital One Platform)을 발표했습니다. 이 휴대용 기기는 클리닉이나 약국 등에서 단 20분 만에 50개 이상의 실험실 수준의 혈액 검사 결과를 제공합니다. 이 플랫폼은 혈액학, 임상화학, 면역측정을 하나의 기기에 통합하여 의료진은 한 번의 검사로 검사, 진단, 치료를 할 수 있습니다. 이 혁신은 기존 임상 검사에 필적하는 정확도를 유지하면서 환자 치료의 접근성, 속도, 개별화를 개선할 수 있는 기술입니다.

2023년 5월, 미국의 Point-of-Care 검사 장비 제조업체인 PTS Diagnostics는 BIOSYNEX S.A.와 파트너십을 맺고 전 세계 만성질환 환자 치료를 강화합니다. 이번 제휴는 Point-of-Care의 지질 및 A1C 검사 서비스를 확대하여 전 세계에서 심혈관 및 당뇨병 치료를 개선하는 것을 목표로 합니다. 프랑스에 본사를 둔 바이오시넥스(BIOSYNEX)는 POC(Point-Of-Care) 지질 검사 솔루션을 포함한 신속 진단 검사 개발 및 판매를 전문으로 하는 기업입니다.

Point Of Care 지질검사 시장은 지질 프로파일 검사 서비스, 진단 지원 서비스, 재택 검사 서비스, 기술 지원 서비스 등의 서비스를 제공하는 사업자가 얻는 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. POC(Point-Of-Care) 지질 검사 시장에는 테스트 스트립, 지질 패널 분석기, 휴대용 지질 검사 장비, 콜레스테롤 검사 장비, 다중 매개 변수 검사 장비, 랜싯, 제어 솔루션, 시약 키트, 무선 지질 검사 장비, 블루투스 지원 지질 모니터 판매가 포함됩니다. 즉, 상품의 제조업체 또는 공급자가 다른 사업자(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 POC(Point Of Care) 지질 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 용도 산업의 분석
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 성장률 분석
  • 세계의 POC(Point Of Care) 지질 검사 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 POC(Point Of Care) 지질 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 POC(Point Of Care) 지질 검사 : TAM(Total Addressable Market)

제6장 시장 세분화

  • 세계의 POC(Point Of Care) 지질 검사 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 측정 기기
  • 소모품
  • 기타 제품 유형
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 고지혈증
  • 고중성지방혈증
  • 탄지에르병
  • 고리포 단백질 혈증
  • 가족성 고콜레스테롤혈증
  • 기타 용도
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 병원
  • 클리닉
  • 진단 실험실
  • 홈케어 설정
  • 기타 최종사용자
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 서브 세분화 기기, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 벤치탑형 분석기
  • 휴대용 또는 핸드헬드 분석기
  • 멀티파라미터 분석기
  • 싱글 파라미터 분석기
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 서브 세분화 소모품, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 검사 스트립
  • 시약과 키트
  • 품질관리 재료
  • 캘리브레이터
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 서브 세분화 기타 제품 유형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 소프트웨어 솔루션
  • 부속품
  • 데이터 관리와 접속 툴

제7장 지역별·국가별 분석

  • 세계의 POC(Point Of Care) 지질 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 POC(Point Of Care) 지질 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • POC(Point Of Care) 지질 검사 시장 : 경쟁 구도
  • POC(Point Of Care) 지질 검사 시장 : 기업 개요
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

  • Bio-Rad Laboratories Inc.
  • Horiba ABX SAS
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Fisher Scientific International Inc.
  • Everlywell Inc.
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • VivaChek Biotech(Hangzhou) Co. Ltd.
  • EuroMedix International NV
  • A. Menarini Industrie Farmaceutiche Riunite S.r.l.
  • AccuBioTech Co. Ltd.
  • Callegari S.r.l.
  • MiCo BioMed Co. Ltd.
  • BHR Diagnostics Private Limited

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • POC(Point Of Care) 지질 검사 시장 2029 : 새로운 기회를 제공하는 국가
  • POC(Point Of Care) 지질 검사 시장 2029 : 새로운 기회를 제공하는 부문
  • POC(Point Of Care) 지질 검사 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁사 전략

제36장 부록

KSA 25.11.12

A point of care lipid test is a rapid diagnostic test that uses a fingerstick blood sample to measure cholesterol and triglyceride levels without sending samples to a central laboratory. It provides fast results to support cardiovascular risk assessment and ongoing monitoring.

The primary product types of point of care lipid tests are instruments, consumables, and others. Instruments include portable analyzers and testing devices designed to quickly assess lipid profiles, such as cholesterol and triglyceride levels, at or near the patient care site. These solutions are applied in conditions such as hyperlipidemia, hypertriglyceridemia, Tangier disease, hyperlipoproteinemia, familial hypercholesterolemia, and others. Key end users include hospitals, clinics, diagnostic laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point of care lipid test market research report is one of a series of new reports from The Business Research Company that provides point of care lipid test market statistics, including the point of care lipid test industry global market size, regional shares, competitors with the point of care lipid test market share, detailed point of care lipid test market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care lipid test industry. This point of care lipid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point of care lipid test market size has grown strongly in recent years. It will grow from $0.68 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period was driven by the rising prevalence of cardiovascular disease and dyslipidemia, expansion of multi-analyte and multiplex testing, increasing healthcare expenditure and reimbursement support, growing awareness and focus on preventive healthcare, and wider adoption in retail pharmacies, clinics, and community settings.

The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period is fueled by increasing adoption in home based and self-monitoring settings, rising awareness and screening for genetic lipid disorders, growing chronic disease burden, the shift toward value based healthcare models, and stable demand for consumables. The primary trends in the forecast period include advancements in portable technology, integration with digital health systems, incorporation into remote patient monitoring and telemedicine platforms, integration within IoMT or connected health infrastructure, and development of edge computing and low-power biosensor chips.

The growing prevalence of cardiovascular diseases is expected to drive the growth of the point-of-care lipid test market. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and hypertension, often resulting from atherosclerosis linked to abnormal cholesterol and triglyceride levels. The rise in cardiovascular diseases is largely due to sedentary lifestyles and decreased physical activity, leading to obesity, poor circulation, and other risk factors. Point-of-care lipid tests play a crucial role in managing this trend by offering rapid, on-site measurement of cholesterol and lipid levels, enabling early identification of risk and timely intervention to prevent further complications. For example, the American Heart Association reported in January 2024 that cardiovascular diseases caused 931,578 deaths, a rise of 3,000 compared to the previous year. This increasing burden of cardiovascular diseases is driving the demand for point-of-care lipid tests.

Leading companies in the point-of-care lipid test market are focusing on advanced diagnostic platforms to improve clinical decision-making and patient management. These platforms are portable, integrated devices capable of performing rapid, lab-quality lipid panel tests at the patient's bedside, allowing real-time decision-making and immediate treatment. For example, in July 2023, Vital Biosciences Inc., a health tech company based in Canada, introduced the VitalOne platform. This portable device delivers over 50 lab-grade blood test results in just 20 minutes at locations such as clinics and pharmacies. The platform combines hematology, clinical chemistry, and immunoassays in one device, enabling healthcare providers to perform testing, diagnosis, and treatment during a single visit. This innovation improves access, speed, and personalization of patient care, while maintaining accuracy comparable to traditional laboratory tests.

In May 2023, PTS Diagnostics, a US-based manufacturer of point-of-care testing devices, partnered with BIOSYNEX S.A. to enhance care for patients with chronic diseases worldwide. The collaboration aims to expand their point-of-care lipid and A1C testing services, improving cardiovascular and diabetes care on a global scale. BIOSYNEX, based in France, specializes in developing and distributing rapid diagnostic tests, including point-of-care lipid testing solutions.

Major players in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.

North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care lipid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care lipid test market consists of revenues earned by entities by providing services such as lipid profile testing services, diagnostic support services, home-based testing services, and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care lipid test market includes the sale of test strips, lipid panel analyzers, handheld lipid testing devices, cholesterol testing devices, multi-parameter testing devices, lancets, control solutions, reagent kits, wireless lipid testing devices, and Bluetooth-enabled lipid monitors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Lipid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care lipid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care lipid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care lipid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Types: Instruments; Consumables; Other Product Types
  • 2) By Application: Hyperlipidemia; Hypertriglyceridemia; Tangier Disease; Hyperlipoproteinemia; Familial Hypercholesterolemia; Other Applications
  • 3) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Analyzers; Portable Or Handheld Analyzers; Multi-parameter Analyzers; Single-parameter Analyzers
  • 2) By Consumables: Test Strips; Reagents And Kits; Quality Control Materials; Calibrators
  • 3) By Other Product Types: Software Solutions; Accessories; Data Management And Connectivity Tools
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Becton Dickinson and Company; Quidel Corporation; Bio-Rad Laboratories Inc.; Horiba ABX SAS; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; Fisher Scientific International Inc.; Everlywell Inc.; EKF Diagnostics Holdings plc; Trinity Biotech plc; VivaChek Biotech (Hangzhou) Co. Ltd.; EuroMedix International NV; A. Menarini Industrie Farmaceutiche Riunite S.r.l.; AccuBioTech Co. Ltd.; Callegari S.r.l.; MiCo BioMed Co. Ltd.; BHR Diagnostics Private Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Lipid Test Market Characteristics

3. Point Of Care Lipid Test Market Trends And Strategies

4. Point Of Care Lipid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Lipid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point Of Care Lipid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point Of Care Lipid Test Market Growth Rate Analysis
  • 5.4. Global Point Of Care Lipid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point Of Care Lipid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point Of Care Lipid Test Total Addressable Market (TAM)

6. Point Of Care Lipid Test Market Segmentation

  • 6.1. Global Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Other Product Types
  • 6.2. Global Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Tangier Disease
  • Hyperlipoproteinemia
  • Familial Hypercholesterolemia
  • Other Applications
  • 6.3. Global Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.4. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benchtop Analyzers
  • Portable Or Handheld Analyzers
  • Multi-parameter Analyzers
  • Single-parameter Analyzers
  • 6.5. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Strips
  • Reagents And Kits
  • Quality Control Materials
  • Calibrators
  • 6.6. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Accessories
  • Data Management And Connectivity Tools

7. Point Of Care Lipid Test Market Regional And Country Analysis

  • 7.1. Global Point Of Care Lipid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point Of Care Lipid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Lipid Test Market

  • 8.1. Asia-Pacific Point Of Care Lipid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Lipid Test Market

  • 9.1. China Point Of Care Lipid Test Market Overview
  • 9.2. China Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Lipid Test Market

  • 10.1. India Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Lipid Test Market

  • 11.1. Japan Point Of Care Lipid Test Market Overview
  • 11.2. Japan Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Lipid Test Market

  • 12.1. Australia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Lipid Test Market

  • 13.1. Indonesia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Lipid Test Market

  • 14.1. South Korea Point Of Care Lipid Test Market Overview
  • 14.2. South Korea Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Lipid Test Market

  • 15.1. Western Europe Point Of Care Lipid Test Market Overview
  • 15.2. Western Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Lipid Test Market

  • 16.1. UK Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Lipid Test Market

  • 17.1. Germany Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Lipid Test Market

  • 18.1. France Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Lipid Test Market

  • 19.1. Italy Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Lipid Test Market

  • 20.1. Spain Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Lipid Test Market

  • 21.1. Eastern Europe Point Of Care Lipid Test Market Overview
  • 21.2. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Lipid Test Market

  • 22.1. Russia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Lipid Test Market

  • 23.1. North America Point Of Care Lipid Test Market Overview
  • 23.2. North America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Lipid Test Market

  • 24.1. USA Point Of Care Lipid Test Market Overview
  • 24.2. USA Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Lipid Test Market

  • 25.1. Canada Point Of Care Lipid Test Market Overview
  • 25.2. Canada Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Lipid Test Market

  • 26.1. South America Point Of Care Lipid Test Market Overview
  • 26.2. South America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Lipid Test Market

  • 27.1. Brazil Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Lipid Test Market

  • 28.1. Middle East Point Of Care Lipid Test Market Overview
  • 28.2. Middle East Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Lipid Test Market

  • 29.1. Africa Point Of Care Lipid Test Market Overview
  • 29.2. Africa Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Lipid Test Market Competitive Landscape And Company Profiles

  • 30.1. Point Of Care Lipid Test Market Competitive Landscape
  • 30.2. Point Of Care Lipid Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Lipid Test Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Horiba ABX SAS
  • 31.3. Randox Laboratories Ltd.
  • 31.4. Sekisui Diagnostics LLC
  • 31.5. Fisher Scientific International Inc.
  • 31.6. Everlywell Inc.
  • 31.7. EKF Diagnostics Holdings plc
  • 31.8. Trinity Biotech plc
  • 31.9. VivaChek Biotech (Hangzhou) Co. Ltd.
  • 31.10. EuroMedix International NV
  • 31.11. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
  • 31.12. AccuBioTech Co. Ltd.
  • 31.13. Callegari S.r.l.
  • 31.14. MiCo BioMed Co. Ltd.
  • 31.15. BHR Diagnostics Private Limited

32. Global Point Of Care Lipid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Lipid Test Market

34. Recent Developments In The Point Of Care Lipid Test Market

35. Point Of Care Lipid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Point Of Care Lipid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point Of Care Lipid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point Of Care Lipid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제